CHD7 and triple-negative breast carcinoma: This association may support the findings from CHD7 knockdown models in triple-negative breast cancer cell lines showing inhibition of cell proliferation and decreased gene expression of several CHD7 targets, including the NRAS oncogene (Chu et al., 2017).